Who are the Institutional Holders in Harpoon Therapeutics Inc (HARP)?

Harpoon Therapeutics Inc (NASDAQ: HARP) is 96.48% higher on its value in year-to-date trading and has touched a low of $3.11 and a high of $22.66 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HARP stock was last observed hovering at around $22.33 in the last trading session, with the day’s gains setting it 0.01%.

Currently trading at $22.34, the stock is -0.24% and 41.97% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.53 million and changing 0.04% at the moment leaves the stock 143.82% off its SMA200. HARP registered 63.07% gain for a year compared to 6-month gain of 176.14%. The firm has a 50-day simple moving average (SMA 50) of $9.68 and a 200-day simple moving average (SMA200) of -$14.23.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


The stock witnessed a -0.09% loss in the last 1 month and extending the period to 3 months gives it a 260.32%, and is 0.13% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 0.39% over the week and 0.50% over the month.

Harpoon Therapeutics Inc (HARP) has around 50 employees, a market worth around $378.66M and $37.34M in sales. Profit margin for the company is -81.68%. Distance from 52-week low is 618.33% and -1.41% from its 52-week high. The company has generated returns on investments over the last 12 months (-189.78%).

Harpoon Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.64 with sales reaching $5.6M over the same period.The EPS is expected to grow by 89.77% this year, but quarterly earnings will post 19.20% year-over-year. Quarterly sales are estimated to grow 37.00% in year-over-year returns.

46 institutions hold shares in Harpoon Therapeutics Inc (HARP), with institutional investors hold 46.67% of the company’s shares. The shares outstanding are 16.95M, and float is at 8.44M with Short Float at 5.63%. Institutions hold 45.39% of the Float.

The top institutional shareholder in the company is BioImpact Capital LLC with over 0.32 million shares valued at $2.27 million. The investor’s holdings represent 0.82% of the HARP Shares outstanding. As of Jun 29, 2023, the second largest holder is MPM Asset Management, LLC with 0.31 million shares valued at $2.22 million to account for 0.81% of the shares outstanding. The other top investors are New Leaf Venture Partners, L.L.C. which holds 0.32 million shares representing 0.81% and valued at over $2.24 million, while Franklin Resources, Inc. holds 0.34% of the shares totaling 0.13 million with a market value of $0.94 million.

Harpoon Therapeutics Inc (HARP) Insider Activity

The most recent transaction is an insider purchase by HUNT RONALD, the company’s Director. SEC filings show that HUNT RONALD bought 10,000 shares of the company’s common stock on Mar 23 at a price of $1.00 per share for a total of $10000.0. Following the purchase, the insider now owns 10000.0 shares.